The Pathophysiology of Sepsis and Precision-Medicine-Based Immunotherapy

Immunotherapy trials for sepsis, mainly aimed at suppressing the immune response have largely failed, in part owing to unresolved patient heterogeneity in the underlying immune disbalance. The past decade has brought the promise to break this blockade through technological developments.